Dr. Thomas A Eschenroeder is a Midlothian, Virginia based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1807 Huguenot Rd, Suite 120, Midlothian. Patients can reach him at 804-354-1600.
Dr. Thomas A Eschenroeder deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Thomas A Eschenroeder speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Thomas A Eschenroeder
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D.D.S.
Accepts Medicare Assignment:
May Accept
Practice Address:
1807 Huguenot Rd, Suite 120, Midlothian, Virginia, 23113-5604
Phone:
804-354-1600
Fax:
804-354-1607
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
3971505082
Enrollment ID:
I20100428000936
NPI Number:
1063462869
NPI Enumeration Date:
11 May, 2006
NPI Last Update On:
09 Jun, 2016
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 71930, Richmond, Virginia
Zip:
23255-1930
Phone Number:
804-354-1600
Fax Number:
804-354-1607
Patients can reach Dr. Thomas A Eschenroeder at 1807 Huguenot Rd, Suite 120, Midlothian, Virginia or can call to book an appointment on 804-354-1600. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.